AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

NYSE:CGCCanopy Growth Stock Price, Forecast & News

$16.33
-0.17 (-1.03 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$16.15
Now: $16.33
$16.68
50-Day Range
$15.91
MA: $17.26
$21.72
52-Week Range
$9.00
Now: $16.33
$39.67
Volume1.99 million shs
Average Volume7.15 million shs
Market Capitalization$5.73 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.58
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Read More
Canopy Growth logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.45 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
Phone855-558-9333

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$297.34 million
Cash Flow$1.52 per share
Book Value$10.95 per share

Profitability

Net Income$-993,370,000.00
Net Margins-752.54%

Miscellaneous

Employees4,434
Market Cap$5.73 billion
Next Earnings Date8/12/2020 (Estimated)
OptionableOptionable

Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Canopy Growth (NYSE:CGC) Frequently Asked Questions

How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CGC shares have increased by 22.3% and is now trading at $16.33. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Canopy Growth?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 3 sell ratings, 14 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Canopy Growth.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Canopy Growth.

How were Canopy Growth's earnings last quarter?

Canopy Growth Corp (NYSE:CGC) issued its quarterly earnings data on Friday, May, 29th. The marijuana producer reported ($1.16) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.30) by $0.86. The marijuana producer had revenue of $80.46 million for the quarter, compared to analysts' expectations of $94.65 million. Canopy Growth had a negative net margin of 752.54% and a negative return on equity of 20.66%. View Canopy Growth's earnings history.

What price target have analysts set for CGC?

22 Wall Street analysts have issued 12-month price objectives for Canopy Growth's stock. Their forecasts range from $15.60 to $60.00. On average, they expect Canopy Growth's stock price to reach $31.92 in the next year. This suggests a possible upside of 95.5% from the stock's current price. View analysts' price targets for Canopy Growth.

Has Canopy Growth been receiving favorable news coverage?

News headlines about CGC stock have been trending negative this week, InfoTrie reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Canopy Growth earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media coverage about the marijuana producer a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Canopy Growth.

Are investors shorting Canopy Growth?

Canopy Growth saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 45,800,000 shares, an increase of 6.2% from the May 31st total of 43,130,000 shares. Based on an average trading volume of 7,210,000 shares, the days-to-cover ratio is currently 6.4 days. Currently, 21.2% of the shares of the company are short sold. View Canopy Growth's Current Options Chain.

Who are some of Canopy Growth's key competitors?

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Aurora Cannabis (ACB), Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), KushCo (KSHB) and Aurora Cannabis (ACB).

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
  • Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
  • Mr. Timothy Rob Saunders, Exec. Officer
  • Mr. Rade Kovacevic, Exec. VP
  • Mr. Mike Lee, Acting Chief Financial Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a variety of retail and institutional investors. Top institutional investors include Tsfg LLC (0.00%) and Modus Advisors LLC (0.00%).

Which major investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Tsfg LLC.

Which major investors are buying Canopy Growth stock?

CGC stock was bought by a variety of institutional investors in the last quarter, including Modus Advisors LLC.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $16.33.

How big of a company is Canopy Growth?

Canopy Growth has a market capitalization of $5.73 billion and generates $297.34 million in revenue each year. The marijuana producer earns $-993,370,000.00 in net income (profit) each year or $1.32 on an earnings per share basis. Canopy Growth employs 4,434 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.